Press releases

18 Jul 2012

Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab

read more
20 Apr 2012

Synthon acquires LEX System from Biolex Therapeutics

read more
22 Mar 2012

Synthon successfully concluded Phase I clinical trial for trastuzumab

read more